Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment

Hila Magen(Sheba Medical Center), Eli Muchtar(Mayo Clinic)
Therapeutic Advances in Hematology
June 10, 2016
Cited by 68


Related Papers